Vaso Corporation

Equities

VASO

US92233F1021

Advanced Medical Equipment & Technology

Delayed OTC Markets Other stock markets 08:57:15 14/05/2024 pm IST			5-day change	1st Jan Change
0.26 ^USD	-3.70%		0.00%	-14.75%

01/04	Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04	Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023

April 02, 2024 at 01:35 am IST

Vaso Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 81.02 million compared to USD 79.29 million a year ago. Net income was USD 4.81 million compared to USD 11.29 million a year ago.

Latest news about Vaso Corporation

Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02/04	CI
Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction.	07/12	CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
Vaso Corporation Appoints Leon Dembo as Independent Director	03/23/03	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17	CI
Vaso Corporation Receives Confirmation That the Small Business Administration Approves the Company's PPP Note Forgiveness Application	25/21/25	CI
Vaso Corporation Announces Earnings Results for the First Quarter Ended March 31, 2021	05/21/05	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	05/21/05	CI
Vaso Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	14/20/14	CI
Vaso : Earnings Flash (VASO) VASO CORPORATION Posts Q3 Revenue $17.5M	13/20/13	MT
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	15/20/15	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	15/20/15	CI
Vaso Corporation Names Jane Moen as Class II Director	31/20/31	CI
Vaso Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	15/19/15	CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	15/19/15	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2018	16/19/16	CI

Chart Vaso Corporation

Duration

Period

More charts

Company Profile

Vaso Corporation is principally engaged in operating the healthcare equipment and information technology industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment operates through a wholly owned subsidiary, VasoTechnology, Inc., which primarily focuses on healthcare information technology (IT) and managed network technology services. Its Professional sales service segment operates through a wholly owned subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare (GEHC) into the health provider middle market. Its Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.

Sector

Advanced Medical Equipment & Technology

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
VASO CORPORATION	-14.75%	4.73Cr
THERMO FISHER SCIENTIFIC	+11.47%	23TCr
DANAHER CORPORATION	+10.48%	19TCr
INTUITIVE SURGICAL, INC.	+12.86%	14TCr
BOSTON SCIENTIFIC CORPORATION	+25.13%	11TCr
SIEMENS HEALTHINEERS AG	+0.91%	6.36TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.74%	5.13TCr
EDWARDS LIFESCIENCES CORPORATION	+11.80%	5.1TCr
AGILENT TECHNOLOGIES, INC.	+8.29%	4.33TCr
GE HEALTHCARE TECHNOLOGIES INC.	+4.87%	3.7TCr

Other Advanced Medical Equipment & Technology